Age 0 3 0 3 B-age
18 4 6 4 6 B-lower_bound
years 7 12 7 12 I-lower_bound
or 13 15 13 15 O
older 16 21 16 21 O

ECOG 0 4 22 26 B-clinical_variable
performance 5 16 27 38 I-clinical_variable
status 17 23 39 45 I-clinical_variable
≤ 24 25 46 47 O
2 26 27 48 49 B-upper_bound
( 28 29 50 51 O
Karnofsky 29 38 51 60 B-clinical_variable
Performance 39 50 61 72 I-clinical_variable
Status 51 57 73 79 I-clinical_variable
≥ 58 59 80 81 O
60 60 62 82 84 B-lower_bound
, 62 63 84 85 O
see 64 67 86 89 O
Appendix 68 76 90 98 O
A 77 78 99 100 O
) 78 79 100 101 O

Individuals 0 11 102 113 O
with 12 16 114 118 O
a 17 18 119 120 O
history 19 26 121 128 O
of 27 29 129 131 O
a 30 31 132 133 O
different 32 41 134 143 O
malignancy 42 52 144 154 B-cancer
are 53 56 155 158 O
ineligible 57 67 159 169 O
except 68 74 170 176 O
for 75 78 177 180 O
the 79 82 181 184 O
following 83 92 185 194 O
circumstances 93 106 195 208 O

Men 0 3 209 212 B-gender
treated 4 11 213 220 O
or 12 14 221 223 O
enrolled 15 23 224 232 O
on 24 26 233 235 O
this 27 31 236 240 O
protocol 32 40 241 249 O
must 41 45 250 254 O
also 46 50 255 259 O
agree 51 56 260 265 B-contraception_consent
to 57 59 266 268 I-contraception_consent
use 60 63 269 272 I-contraception_consent
adequate 64 72 273 281 I-contraception_consent
contraception 73 86 282 295 I-contraception_consent
prior 87 92 296 301 O
to 93 95 302 304 O
the 96 99 305 308 O
study 100 105 309 314 O
, 105 106 314 315 O
for 107 110 316 319 O
the 111 114 320 323 O
duration 115 123 324 332 O
of 124 126 333 335 O
study 127 132 336 341 O
participation 133 146 342 355 O
, 146 147 355 356 O
and 148 151 357 360 O
4 152 153 361 362 B-lower_bound
months 154 160 363 369 I-lower_bound
after 161 166 370 375 O
completion 167 177 376 386 O
of 178 180 387 389 O
proton 181 187 390 396 B-treatment
therapy 188 195 397 404 I-treatment

Patients 0 8 405 413 O
may 9 12 414 417 O
or 13 15 418 420 O
may 16 19 421 424 O
not 20 23 425 428 O
have 24 28 429 433 O
neurofibromatosis 29 46 434 451 B-chronic_disease
type 47 51 452 456 I-chronic_disease
1 52 53 457 458 I-chronic_disease
or 54 56 459 461 I-chronic_disease
2 57 58 462 463 I-chronic_disease

Should 0 6 464 470 O
a 7 8 471 472 O
woman 9 14 473 478 B-gender
become 15 21 479 485 O
pregnant 22 30 486 494 B-pregnancy
or 31 33 495 497 O
suspect 34 41 498 505 O
she 42 45 506 509 O
is 46 48 510 512 O
pregnant 49 57 513 521 O
while 58 63 522 527 O
she 64 67 528 531 O
or 68 70 532 534 O
her 71 74 535 538 O
partner 75 82 539 546 O
is 83 85 547 549 O
participating 86 99 550 563 O
in 100 102 564 566 O
this 103 107 567 571 O
study 108 113 572 577 O
, 113 114 577 578 O
she 115 118 579 582 O
should 119 125 583 589 O
inform 126 132 590 596 O
her 133 136 597 600 O
treating 137 145 601 609 O
physician 146 155 610 619 O
immediately 156 167 620 631 O

The 0 3 632 635 O
effects 4 11 636 643 O
of 12 14 644 646 O
proton 15 21 647 653 B-treatment
radiation 22 31 654 663 I-treatment
therapy 32 39 664 671 I-treatment
on 40 42 672 674 O
the 43 46 675 678 O
developing 47 57 679 689 O
human 58 63 690 695 O
fetus 64 69 696 701 O
are 70 73 702 705 O
known 74 79 706 711 O
to 80 82 712 714 O
be 83 85 715 717 O
teratogenic 86 97 718 729 O

Uncontrolled 0 12 730 742 O
intercurrent 13 25 743 755 O
illness 26 33 756 763 O
including 34 43 764 773 O
, 43 44 773 774 O
but 45 48 775 778 O
not 49 52 779 782 O
limited 53 60 783 790 O
to 61 63 791 793 O
ongoing 64 71 794 801 O
or 72 74 802 804 O
active 75 81 805 811 B-chronic_disease
infection 82 91 812 821 I-chronic_disease
, 91 92 821 822 O
symptomatic 93 104 823 834 O
congestive 105 115 835 845 B-chronic_disease
heart 116 121 846 851 I-chronic_disease
failure 122 129 852 859 I-chronic_disease
, 129 130 859 860 O
unstable 131 139 861 869 B-chronic_disease
angina 140 146 870 876 I-chronic_disease
pectoris 147 155 877 885 I-chronic_disease
, 155 156 885 886 O
cardiac 157 164 887 894 B-chronic_disease
arrhythmia 165 175 895 905 I-chronic_disease
, 175 176 905 906 O
or 177 179 907 909 O
psychiatric 180 191 910 921 O
illness 192 199 922 929 O
/ 199 200 929 930 O
social 200 206 930 936 O
situations 207 217 937 947 O
that 218 222 948 952 O
would 223 228 953 958 O
limit 229 234 959 964 O
compliance 235 245 965 975 O
with 246 250 976 980 O
study 251 256 981 986 O
requirements 257 269 987 999 O

histologically 0 14 1000 1014 O
confirmed 15 24 1015 1024 O
atypical 25 33 1025 1033 B-cancer
meningioma 34 44 1034 1044 I-cancer
, 44 45 1044 1045 O
WHO 46 49 1046 1049 O
grade 50 55 1050 1055 O
II 56 58 1056 1058 O
, 58 59 1058 1059 O
Simpson 60 67 1060 1067 B-clinical_variable
grade 68 73 1068 1073 I-clinical_variable
4 74 75 1074 1075 B-lower_bound
- 75 76 1075 1076 O
5 76 77 1076 1077 B-upper_bound
that 78 82 1078 1082 O
has 83 86 1083 1086 O
been 87 91 1087 1091 O
either 92 98 1092 1098 O
subtotally 99 109 1099 1109 O
resected 110 118 1110 1118 O
or 119 121 1119 1121 O
biopsied 122 130 1122 1130 O

histologically 0 14 1131 1145 O
confirmed 15 24 1146 1155 O
malignant 25 34 1156 1165 B-cancer
/ 34 35 1165 1166 I-cancer
anaplastic 35 45 1166 1176 I-cancer
meningioma 46 56 1177 1187 I-cancer
, 56 57 1187 1188 O
WHO 58 61 1189 1192 O
grade 62 67 1193 1198 O
III 68 71 1199 1202 O
with 72 76 1203 1207 O
any 77 80 1208 1211 O
prior 81 86 1212 1217 B-treatment
surgery 87 94 1218 1225 I-treatment

lactating 0 9 1226 1235 O
women 10 15 1236 1241 B-gender

